Reuters logo
BRIEF-Merck KGaA's Bavencio drug wins EU approval for Merkel cell carcinoma
2017年9月21日 / 早上7点19分 / 1 个月前

BRIEF-Merck KGaA's Bavencio drug wins EU approval for Merkel cell carcinoma

Sept 21 (Reuters) - Merck KGaA:

* European commission approves Bavencio (avelumab) for metastatic Merkel cell carcinoma For the full story: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below